PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28447770
OWN - NLM
STAT- MEDLINE
DA  - 20170427
DCOM- 20170428
LR  - 20170503
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 376
IP  - 17
DP  - 2017 Apr 27
TI  - Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
PG  - 1692-3
LID - 10.1056/NEJMc1702076 [doi]
FAU - Mildiner, Sorcha
AU  - Mildiner S
AD  - Kaplan Medical Center, Rehovot, Israel
FAU - Malnick, Stephen
AU  - Malnick S
AD  - Kaplan Medical Center, Rehovot, Israel
AD  - [email protected]
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Jan 19;376(3):209-220. PMID: 28002688
CIN - N Engl J Med. 2017 Apr 27;376(17 ):1692-1694. PMID: 28445661
MH  - Humans
MH  - *Multiple Sclerosis
MH  - *Multiple Sclerosis, Relapsing-Remitting
MH  - Recurrence
EDAT- 2017/04/28 06:00
MHDA- 2017/04/30 06:00
CRDT- 2017/04/28 06:00
AID - 10.1056/NEJMc1702076 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Apr 27;376(17):1692-3. doi: 10.1056/NEJMc1702076.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>